Camille L. Bedrosian, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 25,000 shares at $139.18 ($3.5M) on 2021-01-15, disclosed to the SEC on 2021-01-19.
Open-market sale of $3.5M RARE by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |